Average Co-Inventor Count = 2.05
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Myelos Corporation (7 from 11 patents)
2. Horizon Therapeutics Usa, Inc. (4 from 8 patents)
3. Horizon Pharma Rheumatology LLC (2 from 9 patents)
4. Crealta Pharmaceuticals LLC (1 from 2 patents)
14 patents:
1. 12188927 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
2. 11982670 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
3. 11639927 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
4. 11598767 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
5. 10823727 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
6. 10139399 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
7. 9377454 - Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
8. 8063016 - Retro-inverso peptides derived from interleukin-6
9. 7754690 - Method of using retro inverso peptides derived from leukemia inhibitory factor
10. 7754688 - Methods of using retro-inverso peptides derived from interleukin-6
11. 7135461 - Retro-inverso peptides derived from interleukin-6
12. 7115571 - Retro-inverso peptides derived from interleukin-3
13. 7109168 - Retro-inverso peptides derived from leukemia inhibitory factor
14. 6458357 - Retro-inverso neurotrophic and analgesic peptides